Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: Radiother Oncol. 2019 Aug 17;142:246–252. doi: 10.1016/j.radonc.2019.07.033

Table 1: Patient characteristics, Surgery and Response Outcome.

Data are presented as n (%) or median (range). Abbreviations: APR = Abdominoperineal Resection; W&W = Watch and Wait; TEM = Transanal Endoscopic Microsurgery; pCR = pathologic Complete Response.

Development cohort (n = 70) Validation cohort (n = 55)
Age (years) 64 (56–69) 64 (56–70)
Sex
Female 23 (33%) 13 (24%)
Male 47 (67%) 42 (76%)
Clinical tumor stage
T2 12 (17%) 0 (0%)
T3 55 (79%) 46 (84%)
T4 3 (4%) 9 (16%)
Clinical nodal stage
N0 3 (4%) 5 (9%)
N1 19 (27%) 15 (27%)
N2 48 (69%) 35 (64%)
Interval to Surgery (days) 54 (49–56) 55 (48–60)
Type of surgery
Sphincter-sparing 64 (91%) 36 (65%)
APR 4 (6%) 18 (33%)
W&W 2 (3%) 0 (0%)
TEM 0 (0%) 1 (2%)
pCR (ypT0N0)
No 58 (83%) 47 (85%)
Yes 12 (17%) 8 (15%)
Near-pCR (ypT0–1N0)
No 49 (70%) 42 (76%)
Yes 21 (30%) 13 (24%)